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Bullet points 
 
• Hyperglycaemia was common on admission in older acute surgical population 
- 7.8% for all patients and 4.0% for those who were not previously known to 
have diabetes  
 
• Only 71.3% of patients had their blood glucose checked on admission and this 
presents a potential missed opportunity for diagnosis  
 
• Hyperglycaemia was not associated with any measured poor outcomes in this 
study (mortality, length of stay, readmission) but this may be due to a type 2 
error 
 
 
Research questions 
 
• What is the prevalence of admission hyperglycaemia in older acute surgical 
patients? 
• What is the impact of hyperglycaemia on 30- and 90-day mortality outcomes 
in these patients? 
• Does admission hyperglycaemia linked to hospital readmission within 30 days 
and length of acute hospital stay? 
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Abstract 
 
Background: The purpose of the study is to examine the prevalence of 
hyperglycaemia in an older acute surgical population and its effect on clinically 
relevant outcomes in this setting.  
 
Methods: Using Older Persons Surgical Outcomes Collaboration (OPSOC) 
multicentre audit data 2014, we examined the prevalence of admission 
hyperglycaemia, and its effect on 30- and 90-day mortality, readmission within 30 
days and length of acute hospital stay using logistic regression models in consecutive 
patients, ≥65 years, admitted to five acute surgical units in the UK hospitals in 
England, Scotland and Wales. Patients were categorised in three groups based on their 
admission random blood glucose: <7.1, between 7.1 and 11.1, and ≥11.1mmol/L.  
 
Results: A total of 411 patients (77.25± 8.14 years) admitted during May & June 
2014 were studied. Only 293 patients (71.3%) had glucose levels recorded on 
admission. The number (%) of patients with a blood glucose <7.1mmol/l, 7.1–
11.1mmol/l and ≥11.1mmol/l were 171(58.4), 99(33.8) and 23(7.8), respectively. On 
univariate analysis, admission hyperglycaemia was not predictive of any of the 
outcomes investigated. Although the characteristics of those with no glucose level 
were not different from the included sample, 30-day mortality was significantly 
higher in those who had not had their admission glucose level checked (10.2% vs. 
2.7%) suggesting a potential type II error. 
 
Conclusion: Despite current guidelines, nearly a third of older people with surgical 
diagnoses did not have their glucose checked on admission highlighting the 
challenges in prognostification and evaluation research to improve care of older frail 
surgical patients.  
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Introduction 
 
Abnormal glucose regulation occurs when people have diabetes or in times of acute 
illness. It results in high blood glucose levels (hyperglycaemia). Diabetes mellitus is 
the clinical condition present when glucose is chronically raised. It can remain 
undiagnosed in asymptomatic individuals (1) and is a risk factor for poor outcome 
following hospital admission (2). Hyperglycaemia is thus common in hospitalised 
patients, irrespective of diabetic status, (3) yet its prevalence in older surgical patients 
is unknown.  
  
Although initially considered an advantageous response to physiological stress, (4) a 
relationship between admission hyperglycaemia and mortality is well established for 
critically ill patients. (5, 6) This association has been studied in the context of 
myocardial infarction, with significantly higher mortality rates reported amongst 
hyperglycaemic patients (8.4% vs. 2.4%, p<0.001). (7) Similar findings have also 
been described, for patients with Acute Coronary Syndrome, (8) Pneumonia, (9) and 
Stroke. (10) In addition, admission hyperglycaemia is associated with other poor 
outcomes, including increased length of hospital stay, hospital readmission, and 
increased risk of infection. (11, 12) 
Evidence suggests that the role of hyperglycaemia as a marker for poor outcomes 
extends further than its current application to critically ill patients. A prospective 
cohort study of 6,187 general medical and surgical patients identified admission 
hyperglycaemia as an independent predictor of mortality (hazard ratio 1.04 per 1.0 
mmol/L increase, 95% confidence interval (CI) 1.02–1.06, p=0.02). (13) When 
considering an elective general surgical population, patients with preoperative random 
glucose levels of 5.6–11.1mmol/l and >11.1mmol/l were 1.7 and 2.1 times more 
likely to die than those with a blood glucose <5.6mmol/l. (14)  
The prevalence of hyperglycaemia in an older acute surgical population specifically, 
and its effect on mortality has not been studied. Measuring blood glucose on 
admission to surgical units is a recommended procedure, (15, 16, 17) however its role 
in surgical decision-making is not explicitly stated. (18) The global increase in ageing 
population means that the number of older people undergoing surgery is increasing at 
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a rate faster than the rate of the overall population. (19) It is therefore important for us 
to establish factors that affect clinical outcomes in this population. Identifying 
patients with high mortality risk early on in admission can help establish an 
appropriate care pathway, direct hospital resources and ultimately reduce morbidity 
and mortality. (20) More recently, hyperglycaemia has also been discussed as a 
predictive factor for the development of subsequent type II diabetes, outlining further 
utility for admission screening. (21) 
The purposes of this study therefore were (1) to establish the prevalence of admission 
hyperglycaemia in an older acute surgical patients, and (2) to examine its effect on 
30- and 90-day mortality outcomes. Secondary purposes were to examine its 
relationship with hospital readmission within 30 days and length of acute hospital 
stay. 
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Methods 
 
As part of the Older Persons Surgical Outcomes Collaboration (OPSOC) 
http://www.opsoc.eu data were collected in five UK hospitals: (1) University Hospital 
of Wales, Cardiff, (2) North Bristol NHS Trust, Bristol, (3) Aberdeen Royal 
Infirmary, Aberdeen, (4) Royal Alexandra Hospital, Glasgow, and (5) Central 
Manchester Foundation Trust, Manchester. Together the study sites have a total 
catchment population of 2.5 million people. The cohort is comprised of all 
consecutive patients, ≥65 years old, who presented to the acute general surgical unit 
of each study site throughout May and June 2014. This multicentre study aimed to 
audit the standard of diabetes care of older people in acute surgical units and thus we 
did not include acute surgical patients who were triaged to other speciality (usually 
acute geriatric medicine) but not transferred to acute surgical admission units. As an 
audit study with 3 month follow up data collection, we limited our baseline data 
collection for two month duration due to logistic reasons.   
 
In order to describe the cohort, demographic data regarding age and gender were 
noted. The results from routine laboratory tests were recorded to characterise some 
co-morbidities. For example anaemia was defined as haemoglobin levels <129g/L, 
hypoalbuminaemia was defined as an albumin <35g/L and polypharmacy was defined 
as a patient using ≥5 medications on admission. The Canadian Study of Health and 
Ageing (CSHA) frailty scale was used to characterise patients on a scale of 1 (very 
fit), to 7 (severely frail) (see Appendix 1). (22) Multimorbidity, defined as the 
coexistence of ≥2 chronic diseases (see Appendix 2). (23,24) Admission random 
blood glucose was measured via a finger prick test with the use of a glucometer.  
While glucose is a continuous variable and it should be treated as such, in this paper 
we have deliberately chosen the universally accepted cut off points for the diagnosis 
of impaired glucose tolerance and diabetes for the following reasons. As an audit 
study the focus was on categorical data collection so as to identify (1) proportion of 
patients who had their glucose checked; (2) the proportion of patients whose glucose 
levels were borderline hyperglycaemia or hyperglycaemia in cases where the levels 
were checked, and to assess whether this is associated with the selected outcomes. 
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For the purpose of quantifying effects on outcomes, patients were categorised into 
three groups based on admission blood glucose level: <7.1mmol/l, 7.1–11.1mmol/l 
and ≥11.1mmol/l. The diabetic status of each patient was established through medical 
notes and drug charts. 
 
Follow-up data were collected using the in-hospital Clinical Portal Systems. Survival 
status was recorded at both 30 and 90-days following admission. Additionally, 
readmission to the hospital within 30-days of discharge was noted. The total length of 
hospital stay for each individual was calculated as whole day integers, rounded up to 
the nearest day.  
 
This study involved the analysis of existing data only and all participants were service 
users. As such, this study was deemed a service evaluation using multicentre-audit 
approach and thus ethical approval was not required. All participating sites acquired 
institutional approvals at respective sites. 
 
Statistical Analysis 
Mean (SD) or median (IQR) for continuous and number (%) for categorical data were 
reported as appropriate. Chi-squared and Fisher’s exact tests were used to compare 
the baseline characteristics amongst the three blood glucose groups. Binary logistic 
regression was used to calculate odds ratios for mortality and hospital readmission 
using admission blood glucose levels of <7.1mmol/l, 7.1-11.1mmol/l and 
≥11.1mmol/l as the predictor variables. The mean length of hospital stay was also 
compared amongst these groups using a one-way analysis of variance test (ANOVA). 
Kruskal-Wallis test was used for non-normally distributed variables. Statistical 
analyses were performer using STATA version 13.0. 
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Results 
 
In all 411 patients aged 65 years or older were studied. The mean (SD) age was 77.3 
(8.1) years and 212 (51.6%) were women. Frailty, defined as a CSHA score of five or 
greater, was present in 113 (27%). Five or medications were used by 279 (67.9%) and 
multimorbidity, defined as two or more co-morbid conditions was present in 304 
(74%). Other biomarkers consistent with frailty were also prevalent; with anaemia 
found in 183 (44.5%) and hypoalbuminaemia in 171 (41.6%). Seventy-nine patients 
(19.2%) had diabetes. In two (0.5%), the prior diabetes status was unknown. Of 330 
patients with no previous history of diabetes a third (n=109) did not have their 
glucose measured at the time of admission. In those who did undergo blood glucose 
measurement 9/221 (4.0%) had an admission glucose value of >=11.1 mmol/L; the 
corresponding percentage of those with hyperglycaemia in patients with known 
diabetes was 14/71 (20.7%). No glucose measurement was recorded in eight patients 
on admission. 
 
Admission blood glucose data were available in only 293 individuals (71.3%), the 
values ranged between 3.3–27.4mmol/L, with a mean value of 7.48 (S.D. 3.21) 
mmol/L. Baseline characteristics of the cohort with admission blood glucose data 
available were compared between three groups (<7.1, 7.1-11.0 and >=11.1 mmol/L) 
(Table 1). Comparison of characteristics between those with available glucose data 
and those who had missing glucose data on admission did not show any significant 
differences (Supplementary Table 1). 171 (58.4%) were normoglycaemic (random 
blood glucose <7.1mmol/l). Twenty three (7.8%) were hyperglycaemic (randomblood 
glucose ≥11.1mmol/l). The remaining 99 (33.8%) individuals had an admission blood 
glucose ranging between 7.1–11.1mmol/l. Individuals with an admission blood 
glucose ≥11.1mmol/l had a significantly higher prevalence of known diabetes 
(P<0.001, Chi-squared test ). There were no other significant differences between the 
three blood glucose groups. 
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Table 1: Distribution of sample characteristics among older acute surgical admissions 
by blood glucose categories 
 
Baseline Characteristic Blood glucose 
 
<7.1mmol/l 
 
N = 171 
Blood glucose 
 
7.1 - 11mmol/l 
 
N = 99 
Blood glucose 
 
≥11.1mmol/l 
 
N = 23 
Total 
 
 
 
N = 293  
 
p 
Age  77.6 (8.3) 77.2 (8.2) 74.4 (7.8) 77.3 (8.1) 
 p = 0.21 
Mean )SD) 
  N (%)  
Sex 
 
Male 78 (45.6) 48 (48.5) 10 (43.5) 136 293 p = 0.86 Female 93 (54.4) 51 (51.5) 13 (56.6) 157 
Past Medical history 
of Diabetes 
 
Yes 
 
29 (17.0) 28 (28.3) 14 (60.9) 71 293 p < 0.001 No 
 
141 (82.5) 71 (71.7) 9 (39.1) 221 
Missing 
 
1 (0.6) 0 (0.0) 0 (0.0) 1 
CSHA frailty score ≥5 
5) 
Yes 49 (28.7) 31 (31.3) 5 (21.7) 85 293  p = 0.63 No 121 (70.8) 67 (67.7) 18 (78.3) 206 
Missing 1 (0.5) 1 (1.0) 0 (0.0) 2 
Polypharmacy 
(>5 medications) 
Yes 120 (70.2) 66 (66.7) 17 (73.9) 203 293 p = 0.74 No 51 (29.8) 33 (33.3) 6 (26.1) 90 
Anaemia 
(Hb <129g/l) 
 
Yes 83 (48.5) 37 (37.4) 7 (30.4) 127 293 p = 0.09 No 88 (51.5) 62 (62.6) 16 (69.6) 166 
Multimorbidity 
 
Yes 129 (75.4) 77 (77.8) 17 (73.9) 223 293  p = 0.88 No 42 (24.6) 22 (22.2) 6 (26.1) 70 
Hypoalbuminemia 
(Albumin <35g/l) 
Yes 
 
81 (47.4) 38 (38.4) 10 (43.5) 129 293  p = 0.36 No 90 (52.6) 61 (61.6) 13 (56.5) 164 
Operation 
 
Yes 
 
39 (22.8) 18 (18.2) 6 (26.1) 63 293  p = 0.61 No  128 (74.9) 78 (78.8) 17 (73.9) 223 
Missing 4 (2.3) 3 (3.0) 0 (0.0) 7 
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Supplementary Table 1: Characteristics comparison between those with and without 
admission blood glucose levels  
 
Baseline Characteristic Blood glucose 
Not Missing 
N = 293 
Blood glucose  
Missing 
N = 118 
Total 
 
N = 411 
Test Statistic 
Age 
 77.2 (8.2) 77.3 (8.0) 77.3 (8.1) p = 0.93 
Mean (SD) 
  N (%)  
Sex 
 
Male 136 (46.4) 63 (53.4) 199 411  p = 0.20 Female 157 (53.6) 55 (46.6) 212 
Past Medical history 
of Diabetes 
 
Yes 
 
71 (24.2) 8 (6.8) 79 411  p <0.001 No  221 (75.4) 109 (92.4) 330 
Missing 
 
1 (0.3) 1 (0.8) 2 
CSHA frailty score 
≥5) 
Yes 85 (29.1) 28 (23.7) 113 411  p = 0.79 No 206 (70.3) 89 (75.4) 295 
Missing 2 (0.7) 1 (0.9) 3 
Polypharmacy 
(>5 medications) 
Yes 203 (69.3) 76 (64.4) 279 411  p = 0.40 No 90 (30.7) 42 (35.6) 132 
Anaemia 
(Hb <129g/l) 
 
Yes 127 (43.3) 56 (47.5) 183 411  p = 0.52 No 166 (56.7) 62 (52.5) 228 
Multimorbidity 
 
Yes 223 (76.1) 81 (68.6) 304 411  p = 0.15 No 70 (23.9) 37 (31.4) 107 
Hypoalbuminemia 
(Albumin <35g/l) 
Yes 
 
129 (44.0) 42 (35.6) 171 411  p = 0.15 No 164 (56.0) 76 (64.4) 240 
Operation 
 
Yes 
 
63 (21.5) 16 (13.6) 79 411 p = 0.08 No 
 
223 (76.1) 101 (85.6) 324 
Missing 7 (2.4) 1 (0.8) 8 
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With regard to the outcomes examined, 20 (4.9%) patients died within 30-days of 
admission and only 8 patients who died had blood glucose measured (40% of those 
who died). At 90-days, 1 patient was lost to follow-up, and of the remaining 410 
individuals, 36 (8.8%) died of whom 22 (61.1%) had blood glucose data on 
admission. Readmission rates were recorded for all 411 patients, and 82 (20.0%) were 
readmitted within 30-days of discharge. Length of hospital stay (LOS) was available 
for 400 (97.3%) patients. The median LOS was 5.5 days with the Inter Quartile Range 
(IQR) of 3-10 days. Similarly, approximately half of those requiring re-admission or 
longer length of stay had missing glucose data.  
 
Unadjusted odds ratios for the outcomes investigated based on admission blood 
glucose levels (N=293) are shown in Table 2. There were no significant associations 
evident between increasing admission blood glucose and any of the outcomes 
investigated. The only difference between the blood glucose groups in terms of 
baseline characteristics was the prevalence of diabetes (see Table 1). As blood 
glucose and diabetes are directly related it was not appropriate to calculate adjusted 
odds ratios for this variable.  
 
Examination of distribution of missing blood glucose data by study site showed only 
one hospital had 100% compliance with blood glucose measurement on admission for 
acute surgical patients. Failure to record this ranged between 30.1% and 48.1% in the 
other four sites. Odds ratios for each outcome, based upon whether or not patients had 
available blood glucose data showed no significant differences except 30-day 
mortality where the mortality rate in those without admission blood glucose level was 
higher (P=0.004) (Table 3).  
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Table 2: Odds Ratios and their corresponding 95% Confidence Intervals for study 
outcomes using admission glucose category of <7.1 mmol/L as the reference group  
 
 
 
 
Cohort Outcomes 
 
Blood glucose 
<7.1mmol/l 
N = 171 
Blood glucose  
7.1 - 11mmol/l 
N = 99 
Blood glucose  
≥11.1mmol/l 
N = 23 
Total 
 
N=293 
Overall P 
Value for 
Logistic 
Regression 
 
Death at 30 days 
 
Dead 
3 (1.8) 5 (5.1) 0 (0.0) 8 (2.7) - 
Alive 
168 (98.2) 94 (94.9) 23 (100) 285 (97.3) - 
OR 
(95% CI) 
 1.00 
 
 
2.98 
(0.70 to 12.74) 
p = 0.14 
 
- - p = 0.339 
 
Death at 90 
days* 
 
Dead 
12 (7.1) 8 (8.1) 2 (8.7) 22 (7.5) 
 
Alive 
158 (92.9) 91 (91.9) 21 (91.3) 270 (92.5) 
 
OR 
(95% CI) 
 
 
1.00 
 
 
1.16 
 (0.46 to2.94) 
p = 0.76 
 
 
1.25 
 (0.26 to 5.99) 
p = 0.78 
 
- p = 0.93 
Readmission 30 
days after 
discharge 
 
Yes 
38 (22.2) 18 (18.2) 9 (39.1) 65 (22.2) 
 
No 
133 (77.8) 81 (81.8) 14 (60.9) 228 (77.8) 
 
OR 
(95% CI) 
 
 
1.00 
 
 
0.78 
 (0.42 to 1.45) 
p = 0.43 
 
 
2.25 
 (0.90 to 5.60) 
p = 0.08 
 
- p = 0.10 
 
Length of 
Hospital stay 
(days) 
 
No. valid 
cases 
 
Median 
(IQR) 
 
166 (97.1) 
 
5 (2 to 9) 
95 (96.0) 
 
7 (3 to 10) 
23 (100.0) 
 
8 (2 to 11) 
284 (96.9) 
 
Kruskal-Wallis 
 
P = 0.10 - - 
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Table 3: Outcome comparison between those with and without admission blood 
glucose levels 
 
 
 
 
 
Cohort Outcomes 
 
Blood glucose 
Not Missing 
N = 293 
Blood glucose  
Missing 
N = 118 
Total 
 
N=411 
 
Death at 30 days 
 
Dead 
8 (2.7) 12 (10.2) 20 (4.9) 
Alive 
285 (97.3) 106 (89.8) 391 (95.1) 
OR 
(95% CI) 
 
 
 
4.03 
(1.60 to 10.14) 
p = 0.004 
- 
 
Death at 90 days 
 
Dead 
22 (7.5) 14 (11.9) 36 (8.8) 
Alive 
270 (92.5) 104 (88.1) 374 (91.2) 
OR 
(95% CI) 
 
 
1.65 
(0.82 to 3.35) 
p = 0.16 
- 
Readmission 30 days after discharge 
 
Yes 
65 (22.2) 17 (14.4) 82 (20.0) 
No 
228 (77.8) 101 (85.6) 329 (80.0) 
OR 
(95% CI) 
 
 
0.59 
(0.33 to 1.06) 
p = 0.07 
- 
 
Length of Hospital stay (days) 
 
No. valid cases 
 
Mean (SD) 
 
284 (96.9) 
 
9.10 (12.5) 
116 (98.3) 
 
9.72 (11.6) 
400 (97.3) 
 
Independent samples t-test 
 
 
 (-3.27 to 2.04) 
p = 0.65 - 
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Discussion 
 
The prevalence of known diabetes in the cohort was high at 19.2%. On admission 
blood glucose levels was recorded in just over two thirds of older people admitted 
with acute surgical diagnoses. This contrasts with the national guidelines’ requirement 
of surgical services to test for diabetes status on admission to hospital (16 17). The 
prevalence of either borderline hyperglycaemia or hyperglycaemia was also high at 
41.6% in those whom blood glucose levels were available. As expected, there was a 
higher prevalence of known diabetes amongst patients with admission 
hyperglycaemia (p<0.001). When considering the 23 hyperglycaemic patients, 9 
(39.1%) did not have a prior diagnosis of diabetes, and the fact that observed 30-day 
mortality rates were significantly higher in those without glucose measurements 
compared with those in whom it was recorded illustrates potential challenges of 
caring for older surgical patients in the acute setting. Thus differential early survival 
rates might have influenced the results of the current study with regard to impact of 
hyperglycaemia on outcomes. The prevalence of diabetes was significantly higher 
amongst patients with available blood glucose values, compared with those without 
(24.2% vs. 6.8%, p<0.001). This suggests that individuals with a past medical history 
of diabetes were more likely to undergo blood glucose testing on admission. This may 
represent a missed opportunity in detecting undiagnosed or late onset diabetes.  
  
This is the first study to investigate the prevalence of admission hyperglycaemia in an 
older acute surgical population and examine its effect on outcomes including 
mortality. Consequently, there are limited studies available with which to compare 
findings. In 1997, Dzankic et al. (18) conducted a prospective cohort study of 544 
older surgical patients in a US setting to investigate the prevalence of hyperglycaemia 
and its predictive value on adverse outcomes in patients ≥70 years (mean age 78 
years), presenting for non-cardiac elective surgery. In contrast to this current report, 
pre-operative blood glucose was investigated as opposed to admission readings. They 
found a similar prevalence of hyperglycaemia (6.8%) and in their study, abnormal 
preoperative glucose was not associated with postoperative mortality (OR 1.53, 95% 
CI 0.51-4.55, p=0.44). However, the fact that all patients studied were considered 
eligible for elective surgery implies that their cohort characteristics may be 
substantially different from current study in which only 19.2% of patients underwent 14  
  
surgery. Furthermore, for some of our cohort this would have been an emergency 
procedure and adverse outcomes are known to occur more frequently following 
emergency surgery. (25) Consequently, it would be difficult to directly compare 
outcomes amongst these varying cohorts of patients.  
Sleiman et al. (26) also investigated the prevalence of hyperglycaemia and its role as a 
predictor of mortality in acutely ill older patients admitted to a sub-intensive (high 
dependency) care unit in Italy (N=1,115). Not surprisingly, the prevalence of diabetes 
in this setting was high at 28.8%. When considering the 822 patients without known 
diabetes, 104 (12.7%) had hyperglycaemia on admission. In contrast to our study, it 
was demonstrated that newly recognised hyperglycaemia (≥10.0 mmol/l) was 
independently associated with mortality (adjusted OR 2.7, 95%CI 1.6-4.8). This may 
have been due to the fact that only non-diabetic patients were included in the analysis, 
and mortality rates amongst hyperglycaemic non-diabetic patients are known to be 
high. (3, 13, 27, 28) With a smaller sample, we were not able to make this distinction, 
and thus this relationship may have been concealed, furthermore, the high dependency 
setting implied a more unwell population thus a direct comparison with our study is 
problematic.     
Additional studies have used lower random blood glucose cut off levels when 
establishing the prevalence of hyperglycaemia. Noordzij et al. (14) conducted a case-
control study of general surgical patients in the Netherlands, in which an admission 
random blood glucose <5.6mmol/l was considered normal. Of the 2,151 patients with 
admission blood glucose data available, 829 (38.5%) were normoglycaemic. This is 
considerably lower than the 171 (58.4%) individuals defined as normoglycaemic 
when using a random blood glucose level of <7.1mmol/l in our study. Unlike our 
study, preoperative hyperglycaemia levels ≥11.1mmol/l were associated with 
increased mortality (adjusted OR 2.1, 95% CI 1.3–3.5; p<0.001). However,  
comparison with our study is again difficult due to the fact that the authors  did not 
consider older patients specifically, but rather studied all surgical patients aged over 
15 years.  
To date, this is one of the first studies to establish the prevalence of hyperglycaemia 
specifically within an older acute surgical population. Its multi-centre design  across 
five UK hospital sites, representing both urban and rural populations and significant 15  
  
total catchment population imply good  generalisability to the UK population and 
should be representative of NHS health care provision. Each patient’s diabetic status 
was established through analysis of medical notes and drug charts, which is generally 
accepted as a reliable data source. 
 
Whilst our results highlight the current variation in routine clinical practice among 
different regional centres within the UK, an inherent limitation of this study with 
regard to examining the relationship between hyperglycaemia and outcome 
relationship was based on a subset of the study population with available admission 
glucose levels. The number of outcomes observed in the hyperglycaemia group were 
relatively small in those with available glucose data with a sample size of 293. It is 
likely to have affected our ability to detect any significant associations between 
admission hyperglycaemia and outcomes. This is demonstrated by the wide 
confidence intervals generated. It is possible that the non-significant findings are the 
result of a type II statistical error.  
 
Identifying hyperglycaemia on admission regardless of diabetic status will aid patient 
care on a number of levels. There is increasing evidence to suggest that treatment of 
hyperglycaemia with insulin-based regimes is beneficial in reducing morbidity and 
mortality. (29) Additionally, screening provides an opportunity to identify patients 
with possible undiagnosed diabetes. (30) Further studies also describe an association 
between admission hyperglycaemia and 3-year type II diabetes risk, which increased 
from <1% for a glucose ≤5mmol/l to 15% at 15mmol/l. (21) This suggests that 
admission screening will identify patients at high risk of developing diabetes in the 
future, for whom health promotion strategies can be targeted. Furthermore, patients 
with available admission glucose levels might have been offered appropriate 
treatments for hyperglycaemia thus explaining 30-day mortality rates difference 
between two groups (see Table 3). This further highlights the fact that checking 
glucose at point of care might represent a valuable opportunity. 
 
A substantial proportion of patients failed to receive an admission blood glucose test 
in accordance with current guidelines. (15, 16, 17) Although, 89.9% of diabetic 
individuals did have blood glucose data available, this is sub-optimal. Similarly, it is 
concerning that 33.0% of non-diabetic individuals did not have blood glucose data 16  
  
recorded. The extent of missing data was not equally distributed amongst the hospital 
sites investigated. One site had blood glucose data available for 100% of patients, 
demonstrating that this is a feasible practice to achieve and highlights the variation in 
practices in surgical units. Variation in services and outcomes has been well 
recognised. Case mix adjustment taking into account individual prognostic indicators 
thus constitute as vital information in evaluation of performance of surgical units. 
Further, it is good clinical practice to adhere to clinical guidelines and our study 
highlights the challenges in prognostification and health services research involving 
older surgical patients. Therefore, efforts to improve compliance with blood glucose 
screening should therefore be a key implication for policy and practice.  
 
The aim of this study was to establish the prevalence of hyperglycaemia in an older 
acute surgical population and this was achieved.  However, one limitation was the 
failure to distinguish between stress hyperglycaemia and undiagnosed type II diabetes 
as the cause of hyperglycaemia in patients without diabetes. The role of glycosylated 
haemoglobin (HbA1c) has been discussed in this context. (31, 32) HbA1c represents 
the average plasma glucose level haemoglobin is exposed to within its 90-day 
lifespan, and thus is far less influenced by acute illness (33). Since 2010, HbA1c has 
been a recognised method of diagnosing diabetes and testing in this context may 
prove useful. HbA1c testing should be incorporated into future research to provide 
insight into the proportion of older surgical patients affected by these varying forms 
of hyperglycaemia and the influence they have on clinical outcomes.  
 
While our analysis used categorical glucose levels hence reduced the statistical 
power, as an audit study the focus was on categorical data collection so as to identify 
(1) proportion of patients who had their glucose checked; (2) the proportion of 
patients whose glucose levels were borderline hyperglycaemia or hyperglycaemia in 
cases where the levels were checked, and to assess whether this is associated with the 
selected outcomes.  
 
In summary, we found no significant association between hyperglycaemia and the 
outcomes examined although we were not able to exclude a type II error. Further 
research, involving a larger sample, is needed to verify these  findings, perhaps 
utilising glycated HbA1c to differentiate between diabetes and stress hyperglycaemia. 17  
  
Establishing the underlying causes of hyperglycaemia would also be beneficial in 
gaining better understanding and deeper insight to current knowledge. Our study 
highlights the fact that a significant number of older acute surgical patients are not 
receiving blood glucose testing on hospital admission. Our results highlight the 
challenges in prognosis and health service evaluation research for benchmarking and 
quality improvement purposes in older acute surgical populations. Efforts should be 
made to increase admission blood glucose screening for older surgical patients, in 
accordance with current guidelines.   
18  
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